ANGLE PLC

AGL

Company Profile

  • Business description

    ANGLE PLC is active in the healthcare sector in the United Kingdom. The Company's principal trading activity is undertaken in relation to the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy that is non-invasive cancer diagnostics. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of its revenue is generated from Europe.

  • Contact

    10 Nugent Road
    The Surrey Research Park
    Surrey
    GuildfordGU2 7AF
    GBR

    T: +44 1483343434

    E: [email protected]

    https://www.angleplc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    119

Stocks News & Analysis

stocks

Chart of the Week: Opportunities with wide-moat retailers

Consumer defensive names look undervalued.
stocks

New ASX share added to our best ideas

Earnings outlook is strong and the shares trade at a discount to our fair value.
stocks

Fair value downgraded for ASX heavyweight

Our capital allocation rating was also lowered due to balance sheet weakness.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,240.3042.600.46%
CAC 408,060.1793.221.17%
DAX 4024,416.71303.091.26%
Dow JONES (US)46,441.1043.210.09%
FTSE 1009,457.5011.070.12%
HKSE27,287.12431.561.61%
NASDAQ22,755.1695.150.42%
Nikkei 22544,936.73385.880.87%
NZX 50 Index13,451.7617.770.13%
S&P 5006,711.2022.740.34%
S&P/ASX 2008,945.9040.100.45%
SSE Composite Index3,882.7820.250.52%

Market Movers